Exelixis Inc (NASDAQ: EXEL) kicked off on Tuesday, down -0.95% from the previous trading day, before settling in for the closing price of $41.75. Over the past 52 weeks, EXEL has traded in a range of $21.36-$48.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 17.51%. While this was happening, its average annual earnings per share was recorded 50.12%. With a float of $263.89 million, this company’s outstanding shares have now reached $275.03 million.
Let’s determine the extent of company efficiency that accounts for 1147 employees. In terms of profitability, gross margin is 96.78%, operating margin of 33.15%, and the pretax margin is 36.45%.
Exelixis Inc (EXEL) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Exelixis Inc is 3.23%, while institutional ownership is 92.62%. The most recent insider transaction that took place on Jun 02 ’25, was worth 805,140. In this transaction Director of this company sold 18,838 shares at a rate of $42.74, taking the stock ownership to the 21,380 shares. Before that another transaction happened on Jun 03 ’25, when Company’s Director sold 7,535 for $43.09, making the entire transaction worth $324,683. This insider now owns 358,882 shares in total.
Exelixis Inc (EXEL) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 50.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.28% during the next five years compared to 11.55% growth over the previous five years of trading.
Exelixis Inc (NASDAQ: EXEL) Trading Performance Indicators
Take a look at Exelixis Inc’s (EXEL) current performance indicators. Last quarter, stock had a quick ratio of 3.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.91. Likewise, its price to free cash flow for the trailing twelve months is 13.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.20, a number that is poised to hit 0.64 in the next quarter and is forecasted to reach 3.04 in one year’s time.
Technical Analysis of Exelixis Inc (EXEL)
Looking closely at Exelixis Inc (NASDAQ: EXEL), its last 5-days average volume was 2.42 million, which is a drop from its year-to-date volume of 2.83 million. As of the previous 9 days, the stock’s Stochastic %D was 21.50%. Additionally, its Average True Range was 1.16.
During the past 100 days, Exelixis Inc’s (EXEL) raw stochastic average was set at 55.75%, which indicates a significant increase from 11.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.11% in the past 14 days, which was lower than the 43.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.78, while its 200-day Moving Average is $34.63. However, in the short run, Exelixis Inc’s stock first resistance to watch stands at $41.89. Second resistance stands at $42.43. The third major resistance level sits at $42.80. If the price goes on to break the first support level at $40.98, it is likely to go to the next support level at $40.61. Now, if the price goes above the second support level, the third support stands at $40.07.
Exelixis Inc (NASDAQ: EXEL) Key Stats
The company with the Market Capitalisation of 11.28 billion has total of 272,708K Shares Outstanding. Its annual sales at the moment are 2,169 M in contrast with the sum of 521,270 K annual income. Company’s last quarter sales were recorded 555,450 K and last quarter income was 159,620 K.
